Compare Adaptive Biotechnologies Corp (ADPT) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Amylx Pharmaceuticals Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap. Which is the better fit depends on your goals.
| ADPT | AMLX | |
|---|---|---|
Market Cap | $4.04B | $2.64B |
Sector | Health | Health |
52-Week High | $25.45 | $24.19 |
52-Week Low | $12.30 | $7.82 |
Enterprise Value | $4.10B | $2.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
